Prostate cancer and microRNAs: New insights into apoptosis

J Gupta, WK Abdulsahib, AT Jalil, DS Kareem… - … -Research and Practice, 2023 - Elsevier
Prostate cancer (PCa) is known as one of the most prevalent malignancies globally and is
not yet curable owing to its progressive nature. It has been well documented that Genetic …

Long non-coding RNAs and melanoma: From diagnosis to therapy

F Dashti, SMA Mirazimi, G Kazemioula… - … -Research and Practice, 2023 - Elsevier
Although extremely rare, malignant melanoma is the deadliest type of skin malignancy with
the inherent capability to invade other organs and metastasize to distant tissues. In 2021, it …

MicroRNA-155 and cancer metastasis: Regulation of invasion, migration, and epithelial-to-mesenchymal transition

H Moutabian, UK Radi, AY Saleman, M Adil… - … -Research and Practice, 2023 - Elsevier
Among the leading causes of death globally has been cancer. Nearly 90% of all cancer-
related fatalities are attributed to metastasis, which is the growing of additional malignant …

MASP2 inhibition by narsoplimab suppresses endotheliopathies characteristic of transplant-associated thrombotic microangiopathy: in vitro and ex vivo evidence

S Elhadad, D Redmond, J Huang, A Tan… - Clinical and …, 2023 - academic.oup.com
Transplant-associated thrombotic microangiopathy (TA-TMA) is an endotheliopathy
complicating up to 30% of allogeneic hematopoietic stem cell transplants (alloHSCT) …

[HTML][HTML] GRB10 is a novel factor associated with gastric cancer proliferation and prognosis

LL Ren, ZW Wang, R Sen, ZT Dai, XH Liao… - Aging (Albany …, 2023 - ncbi.nlm.nih.gov
GRB10 and its family members GRB7 and GRB14 were important adaptor proteins. They
regulated many cellular functions by interacting with various tyrosine kinase receptors and …

The key role of microRNA-766 in the cancer development

J Gupta, HRA Kareem Al-Hetty, MS Aswood… - Frontiers in …, 2023 - frontiersin.org
Cancer is caused by defects in coding and non-coding RNAs. In addition, duplicated
biological pathways diminish the efficacy of mono target cancer drugs. MicroRNAs (miRNAs) …

Role of Non-coding RNAs in the Response of Glioblastoma to Temozolomide

P Goleij, G Pourali, A Raisi, F Ravaei, S Golestan… - Molecular …, 2024 - Springer
Chemotherapy and radiotherapy are widely used in clinical practice across the globe as
cancer treatments. Intrinsic or acquired chemoresistance poses a significant problem for …

Role of circRNAs in regulating cell death in cancer: a comprehensive review

MJ Saadh, HM Ehymayed, TS Alazzawi… - Cell Biochemistry and …, 2024 - Springer
Despite multiple diagnostic and therapeutic advances, including surgery, radiation therapy,
and chemotherapy, cancer preserved its spot as a global health concern. Prompt cancer …

Systemic lupus erythematosus: From non-coding RNAs to exosomal non-coding RNAs

MTN Nezhad, M Rajabi, P Nekooeizadeh… - … -Research and Practice, 2023 - Elsevier
Systemic lupus erythematosus (SLE), as an immunological illness, frequently impacts young
females. Both vulnerabilities to SLE and the course of the illness's clinical symptoms have …

MicroRNA as Key Players in Hepatocellular Carcinoma: Insights into Their Role in Metastasis

MJ Saadh, QM Hussain, TS Alazzawi, AA Fahdil… - Biochemical …, 2024 - Springer
Liver cancer or hepatocellular carcinoma (HCC) remains the most common cancer in global
epidemiology. Both the frequency and fatality of this malignancy have shown an upward …